Further exploration of the interaction between HA degradation and cellular metabolism as well as signaling through other HA receptors, such as HA-mediated motility receptor (RHAMM), may provide more insight into the understanding of a pro-tumor TME with an HA-rich stroma and how such a TME can be more effectively targeted by anti-cancer therapies. Here, HMMR is linked to cancer.